BioNTech SE (BNTX) Non-cash Items (2021 - 2022)
BioNTech SE (BNTX) reported Non-cash Items of $18.5 billion for Q3 2022, up 80.26% on a YoY basis from $10.3 billion in Q3 2021, and up 80.26% sequentially from $10.3 billion in Q3 2021.
BioNTech SE (BNTX) Non-cash Items (2021 - 2022) Analysis & Trends
BioNTech SE (BNTX) has 2 years of Non-cash Items data on file, last reported at $18.5 billion in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 18.52 Bn |
| Sep 30, 2022 | 18.52 Bn |
| Sep 30, 2021 | 10.27 Bn |
| Sep 30, 2021 | 10.27 Bn |